Heart arrhythmias are a significant global burden, affecting millions of lives.  For example, Atrial fibrillation (AFib), the most common arrhythmia, impacts over 33.5 million individuals globally and more than 3 million in the US. With an aging population, the number of only AFib cases is projected to surge by 40% in the next 15 years, surpassing 7 million individuals by 2035. The economic impact is immense, with billions spent annually on cardiovascular diseases.

Unfortunately, existing diagnostic tools often lead to delayed interventions, as they primarily focus on reactive care, providing ECG analysis results after days of monitoring. This delay hampers timely and life-saving interventions, a critical aspect of effective heart complication management.

With CardioPhi, we aim to transform the way heart health is managed, placing a special emphasis on proactive and personalized cardiac care. Our AI-driven technology provides real-time ECG interpretation, including predicting cardiac arrhythmias and offering on-demand ECG analysis, thus enabling timely interventions and fostering better health outcomes.